Y-Intercept (HK)’s iShares US Medical Devices ETF IHI Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
Sell
-4,327
Closed -$231K 1927
2026
Q1
$231K Buy
+4,327
New +$254K ﹤0.01% 1424
2025
Q2
Sell
-7,056
Closed -$425K 1800
2025
Q1
$425K Buy
+7,056
New +$438K 0.03% 773
2024
Q4
Sell
-9,655
Closed -$572K 1408
2024
Q3
$572K Buy
+9,655
New +$551K 0.04% 720
2024
Q2
Sell
-5,277
Closed -$309K 1620
2024
Q1
$309K Buy
+5,277
New +$298K 0.02% 940
2023
Q4
Sell
-46,322
Closed -$2.25M 1417
2023
Q3
$2.25M Buy
46,322
+41,473
+855% +$2.21M 0.22% 114
2023
Q2
$274K Sell
4,849
-56
-1% -$3.08K 0.03% 806
2023
Q1
$265K Buy
+4,905
New +$261K 0.03% 831
2022
Q1
Sell
-3,932
Closed -$259K 825
2021
Q4
$259K Sell
3,932
-7,862
-67% -$503K 0.06% 440
2021
Q3
$740K Buy
+11,794
New +$752K 0.13% 238

Other funds holding IHI

Y-Intercept (HK)'s IHI Position: Q2 2026 in Review

Y-Intercept (HK) sold out of iShares US Medical Devices ETF (IHI) in Q2 2026, closing a stake of 4,327 shares — an estimated $231K sold.

Y-Intercept (HK) first reported a position in IHI in Q3 2021 and held it in 9 quarters. The position peaked at $2.25M in Q3 2023. 67 funds tracked by Wall St. Rank hold IHI as of Q2 2026.

  • Y-Intercept (HK) reported no remaining iShares US Medical Devices ETF position as of Q2 2026 after selling out during the quarter.
  • Y-Intercept (HK) sold 4,327 iShares US Medical Devices ETF shares in Q2 2026, an estimated $231K.
  • Y-Intercept (HK) first reported a position in iShares US Medical Devices ETF in Q3 2021 and held it in 9 quarters.
  • Y-Intercept (HK)'s iShares US Medical Devices ETF position peaked at $2.25M in Q3 2023.
  • 67 funds tracked by Wall St. Rank held iShares US Medical Devices ETF as of Q2 2026.

Based on Y-Intercept (HK)'s 13F filing for Q2 2026, filed 14 Jul 2026.